Corrigendum: Antimicrobial resistance in the COVID-19 landscape: is there an opportunity for anti-infective antibodies and antimicrobial peptides?

José M. Pérez de la Lastra,Uttpal Anand,Sergio González-Acosta,Manuel R. López,Abhijit Dey,Elza Bontempi,Antonio Morales delaNuez

DOI: https://doi.org/10.3389/fimmu.2024.1365827

IF: 7.3

2024-01-26

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2022.921483.].

immunology

What problem does this paper attempt to address?

Corrigendum: Antibiotic Resistance in Salmonella Typhimurium Isolates Recovered from the Food Chain Through National Antimicrobial Resistance Monitoring System Between 1996 and 2016

Xuchu Wang,Sanket Biswas,Narayan Paudyal,Hang Pan,Xiaoliang Li,Weihuan Fang,Min Yue

DOI: https://doi.org/10.3389/fmicb.2020.01738

IF: 5.2

2020-01-01

Frontiers in Microbiology

Abstract:[This corrects the article DOI: 10.3389/fmicb.2019.00985.].
Corrigendum to “antibacterial Coaxial Hydro-Membranes Accelerate Diabetic Wound Healing by Tuning Surface Immunomodulatory Functions” [mater. Today Bio, 16 (2022)]

Wei Zhang,Sizhan Xia,Tingting Weng,Min Yang,Jiaming Shao,Manjia Zhang,Jialiang Wang,Pengqin Xu,Jintao Wei,Ronghua Jin,Meirong Yu,Zhongtao Zhang,Chunmao Han,Xingang Wang

DOI: https://doi.org/10.1016/j.mtbio.2023.100631

IF: 8.2

2023-01-01

Materials Today Bio

Abstract:[This corrects the article DOI: 10.1016/j.mtbio.2022.100395.].
Erratum: Synthesis and photodynamic antimicrobial chemotherapy against multi-drug resistant Proteus mirabilis of ornithine-porphyrin conjugates in vitro and in vivo

Frontiers Production Office

DOI: https://doi.org/10.3389/fmicb.2023.1260368

IF: 5.2

2023-08-09

Frontiers in Microbiology

Abstract:[This corrects the article DOI: 10.3389/fmicb.2023.1196072.].

microbiology
Corrigendum: A Systematic Study of the Stability, Safety, and Efficacy of the de novo Designed Antimicrobial Peptide PepD2 and Its Modified Derivatives Against Acinetobacter baumannii

Sung-Pang Chen,Eric H-L Chen,Sheng-Yung Yang,Pin-Shin Kuo,Hau-Ming Jan,Tsai-Chen Yang,Ming-Yen Hsieh,Kung-Ta Lee,Chun-Hung Lin,Rita P-Y Chen

DOI: https://doi.org/10.3389/fmicb.2021.821347

IF: 5.2

2022-01-14

Frontiers in Microbiology

Abstract:[This corrects the article DOI: 10.3389/fmicb.2021.678330.].

microbiology
Corrigendum: Alternative Splicing: a New Cause and Potential Therapeutic Target in Autoimmune Disease.

Pingping Ren,Luying Lu,Shasha Cai,Jianghua Chen,Weiqiang Lin,Fei Han

DOI: https://doi.org/10.3389/fimmu.2024.1513491

IF: 7.3

2024-01-01

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2021.713540.].
Correction to "Antibiotic Adjuvants: A Versatile Approach to Combat Antibiotic Resistance"

Geetika Dhanda,Yash Acharya,Jayanta Haldar

DOI: https://doi.org/10.1021/acsomega.4c05153

IF: 4.1

2024-06-18

ACS Omega

Abstract:[This corrects the article DOI: 10.1021/acsomega.3c00312.][This corrects the article DOI: 10.1021/acsomega.3c03063.].
Correction to “Targeting the Spike: Repurposing Mithramycin and Dihydroergotamine to Block SARS-CoV-2 Infection”

Soledad Stagnoli,Gabriele Macari,Pietro Corsi,Barbara Capone,Ander Vidaurrazaga,June Ereño-Orbea,Ana Ardá,Fabio Polticelli,Jesus Jimenez-Barbero,Nicola Ga Abrescia,Ivan Coluzza,Nicola GA Abrescia

DOI: https://doi.org/10.1021/acsomega.3c10152

IF: 4.1

2024-01-18

ACS Omega

Abstract:[This corrects the article DOI: 10.1021/acsomega.3c02921.].

chemistry, multidisciplinary
Corrigendum to ‘Evidences and perspectives of the use of probiotics, prebiotics, synbiotics, and postbiotics as adjuvants for prevention and treatment of COVID-19: A bibliometric analysis and integrative review’ [Trends in Food Science & Technology 120 (2022) 174–192]

Douglas Xavier-Santos,Marina Padilha,Giovanna Alexandre Fabiano,Gabriel Vinderola,Adriano Gomes Cruz,Katia Sivieri,Adriane Elisabete Costa Antunes

DOI: https://doi.org/10.1016/j.tifs.2022.01.028

2022-03-01

Abstract:[This corrects the article DOI: 10.1016/j.tifs.2021.12.033.].

food science & technology
Corrigendum: Advancement in the Development of Therapeutics Against Zika Virus Infection

Kangchen Li,Qianting Ji,Shibo Jiang,Naru Zhang

DOI: https://doi.org/10.3389/fcimb.2022.1006226

IF: 6.073

2022-01-01

Frontiers in Cellular and Infection Microbiology

Abstract:[This corrects the article DOI: 10.3389/fcimb.2022.946957.].
Corrigendum: Microbiome Crosstalk in Immunotherapy and Anti-Angiogenesis Therapy

Xueting Wan,Mengyao Song,Aiyun Wang,Yang Zhao,Zhonghong Wei,Yin Lu

DOI: https://doi.org/10.3389/fimmu.2022.887775

IF: 7.3

2022-04-21

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2021.747914.].

immunology
Corrigendum: Development of phage cocktails to treat E. coli catheter-associated urinary tract infection and associated biofilms

Belkys C. Sanchez,Emmaline R. Heckmann,Sabrina I. Green,Justin R. Clark,Heidi B. Kaplan,Robert F. Ramig,Kenneth L. Muldrew,Casey Hines-Munson,Felicia Skelton,Barbara W. Trautner,Anthony W. Maresso

DOI: https://doi.org/10.3389/fmicb.2022.953136

IF: 5.2

2022-08-09

Frontiers in Microbiology

Abstract:[This corrects the article DOI: 10.3389/fmicb.2022.796132.].

microbiology
Correction: Correia et al. Beyond Penicillin: The Potential of Filamentous Fungi for Drug Discovery in the Age of Antibiotic Resistance. 2023, 12, 1250

João Correia,Anabela Borges,Manuel Simões,Lúcia C. Simões

DOI: https://doi.org/10.3390/antibiotics13100944

2024-10-10

Antibiotics

Abstract:Manuel Simões was included as a corresponding author in the original publication [...]

pharmacology & pharmacy,infectious diseases
Corrigendum: Interferon-α2b Treatment for COVID-19

Qiong Zhou,Virginia Chen,Casey P. Shannon,Xiao-Shan Wei,Xuan Xiang,Xu Wang,Zi-Hao Wang,Scott J. Tebbutt,Tobias R. Kollmann,Eleanor N. Fish

DOI: https://doi.org/10.3389/fimmu.2020.615275

IF: 7.3

2020-10-27

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2020.01061.].

immunology
Corrigendum: CD317-Positive Immune Stromal Cells in Human “Mesenchymal Stem Cell” Populations

Alasdair G. Kay,James M. Fox,James P. Hewitson,Andrew P. Stone,Sophie Robertson,Sally James,Xiao-nong Wang,Elizabeth Kapasa,Xuebin B. Yang,Paul G. Genever

DOI: https://doi.org/10.3389/fimmu.2022.1111042

IF: 7.3

2022-12-13

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2022.903796.].

immunology
Erratum to "Fungal cell wall components modulate our immune system" [Cell Surf. 7 (2021) 100067]

Benoit Briard,Thierry Fontaine,Thirumala-Devi Kanneganti,Neil A R Gow,Nicolas Papon

DOI: https://doi.org/10.1016/j.tcsw.2024.100119

2024-01-12

Abstract:[This corrects the article DOI: 10.1016/j.tcsw.2021.100067.].
Erratum: Antibody-based soluble and membrane-bound TWEAK mimicking agonists with FcγR-independent activity

Frontiers Production Office

DOI: https://doi.org/10.3389/fimmu.2023.1353758

2023-12-15

Abstract:[This corrects the article DOI: 10.3389/fimmu.2023.1194610.].
Corrigendum: Combination effect of engineered endolysin EC340 with antibiotics

Hye-Won Hong,Young Deuk Kim,Jaeyeon Jang,Min Soo Kim,Miryoung Song,Heejoon Myung

DOI: https://doi.org/10.3389/fmicb.2023.1281242

2023-08-31

Abstract:[This corrects the article DOI: 10.3389/fmicb.2022.821936.].
Corrigendum to Antibody Response to BNT162b2 Vaccine in Immune Modifiers-Treated Psoriatic Patients

DOI: https://doi.org/10.1177/24755303231195874

Abstract:[This corrects the article DOI: 10.1177/24755303211056059.].
Corrigendum: Immune dysregulation is an important factor in the underlying complications in Influenza infection. ApoH, IL-8 and IL-15 as markers of prognosis

Sara Garcinuño,Antonio Lalueza,Francisco Javier Gil-Etayo,Raquel Diaz-Simón,Ignacio Lizasoain,Ana Moraga,Blanca Diaz-Benito,Laura Naranjo,Oscar Cabrera-Marante,Daniel Enrique Pleguezuelo,Maria Ruiz-Ruigomez,Blanca Ayuso,Estibaliz Arrieta,Dolores Folgueira,Estela Paz-Artal,Cecilia Cueto,Carlos Lumbreras,Antonio Serrano,Manuel Serrano

DOI: https://doi.org/10.3389/fimmu.2024.1472919

2024-08-08

Abstract:[This corrects the article DOI: 10.3389/fimmu.2024.1443096.].
Corrigendum to ‘Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeutics’ [Genes & Diseases10 (2023) 1367–1401]

Uttpal Anand,Abhijit Dey,Arvind K Singh Chandel,Rupa Sanyal,Amarnath Mishra,Devendra Kumar Pandey,Valentina De Falco,Arun Upadhyay,Ramesh Kandimalla,Anupama Chaudhary,Jaspreet Kaur Dhanjal,Saikat Dewanjee,Jayalakshmi Vallamkondu,José M Pérez de la Lastra,Arvind K. Singh Chandel,José M. Pérez de la Lastra

DOI: https://doi.org/10.1016/j.gendis.2024.101211

IF: 7.376

2024-01-01

Genes & Diseases

Abstract:[This corrects the article DOI: 10.1016/j.gendis.2022.02.007.].

genetics & heredity,biochemistry & molecular biology

Corrigendum: Antimicrobial resistance in the COVID-19 landscape: is there an opportunity for anti-infective antibodies and antimicrobial peptides?

Corrigendum: Antibiotic Resistance in Salmonella Typhimurium Isolates Recovered from the Food Chain Through National Antimicrobial Resistance Monitoring System Between 1996 and 2016

Corrigendum to “antibacterial Coaxial Hydro-Membranes Accelerate Diabetic Wound Healing by Tuning Surface Immunomodulatory Functions” [mater. Today Bio, 16 (2022)]

Erratum: Synthesis and photodynamic antimicrobial chemotherapy against multi-drug resistant Proteus mirabilis of ornithine-porphyrin conjugates in vitro and in vivo

Corrigendum: A Systematic Study of the Stability, Safety, and Efficacy of the de novo Designed Antimicrobial Peptide PepD2 and Its Modified Derivatives Against Acinetobacter baumannii

Corrigendum: Alternative Splicing: a New Cause and Potential Therapeutic Target in Autoimmune Disease.

Correction to "Antibiotic Adjuvants: A Versatile Approach to Combat Antibiotic Resistance"

Correction to “Targeting the Spike: Repurposing Mithramycin and Dihydroergotamine to Block SARS-CoV-2 Infection”

Corrigendum to ‘Evidences and perspectives of the use of probiotics, prebiotics, synbiotics, and postbiotics as adjuvants for prevention and treatment of COVID-19: A bibliometric analysis and integrative review’ [Trends in Food Science & Technology 120 (2022) 174–192]

Corrigendum: Advancement in the Development of Therapeutics Against Zika Virus Infection

Corrigendum: Microbiome Crosstalk in Immunotherapy and Anti-Angiogenesis Therapy

Corrigendum: Development of phage cocktails to treat E. coli catheter-associated urinary tract infection and associated biofilms

Correction: Correia et al. Beyond Penicillin: The Potential of Filamentous Fungi for Drug Discovery in the Age of Antibiotic Resistance. 2023, 12, 1250

Corrigendum: Interferon-α2b Treatment for COVID-19

Corrigendum: CD317-Positive Immune Stromal Cells in Human “Mesenchymal Stem Cell” Populations

Erratum to "Fungal cell wall components modulate our immune system" [Cell Surf. 7 (2021) 100067]

Erratum: Antibody-based soluble and membrane-bound TWEAK mimicking agonists with FcγR-independent activity

Corrigendum: Combination effect of engineered endolysin EC340 with antibiotics

Corrigendum to Antibody Response to BNT162b2 Vaccine in Immune Modifiers-Treated Psoriatic Patients

Corrigendum: Immune dysregulation is an important factor in the underlying complications in Influenza infection. ApoH, IL-8 and IL-15 as markers of prognosis

Corrigendum to ‘Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeutics’ [Genes & Diseases10 (2023) 1367–1401]